Nuveen’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Sell
117,502
-173,971
-60% -$1.34M ﹤0.01% 2669
2025
Q4
$2.57M Buy
291,473
+120,428
+70% +$663K ﹤0.01% 2184
2025
Q3
$854K Buy
171,045
+47,690
+39% +$221K ﹤0.01% 2694
2025
Q2
$582K Sell
123,355
-317,206
-72% -$1.39M ﹤0.01% 2832
2025
Q1
$2.02M Buy
440,561
+285,811
+185% +$1.33M ﹤0.01% 2334
2024
Q4
$741K Hold
154,750
﹤0.01% 2832
2024
Q3
$726K Sell
154,750
-372,073
-71% -$1.99M ﹤0.01% 2884
2024
Q2
$2.98M Buy
526,823
+224,173
+74% +$1.16M ﹤0.01% 2190
2024
Q1
$1.24M Buy
302,650
+147,900
+96% +$592K ﹤0.01% 2612
2023
Q4
$653K Buy
154,750
+1,436
+0.9% +$5.79K ﹤0.01% 2919
2023
Q3
$662K Sell
153,314
-246,689
-62% -$1.37M ﹤0.01% 2743
2023
Q2
$2.64M Sell
400,003
-193,685
-33% -$1.24M ﹤0.01% 2228
2023
Q1
$4.03M Buy
593,688
+21,073
+4% +$148K ﹤0.01% 2011
2022
Q4
$4.23M Sell
572,615
-506,276
-47% -$4.93M ﹤0.01% 2004
2022
Q3
$10.7M Buy
1,078,891
+91,106
+9% +$962K ﹤0.01% 1435
2022
Q2
$10.8M Buy
987,785
+7,018
+0.7% +$72.7K ﹤0.01% 1455
2022
Q1
$11.3M Sell
980,767
-15,601
-2% -$205K ﹤0.01% 1562
2021
Q4
$15.6M Buy
996,368
+171,565
+21% +$2.99M ﹤0.01% 1386
2021
Q3
$14.1M Buy
824,803
+588,107
+248% +$10.3M ﹤0.01% 1529
2021
Q2
$5.09M Sell
236,696
-9,053
-4% -$162K ﹤0.01% 2238
2021
Q1
$3.69M Sell
245,749
-6,389
-3% -$103K ﹤0.01% 2321
2020
Q4
$3.31M Buy
252,138
+590
+0.2% +$7.1K ﹤0.01% 2263
2020
Q3
$2.43M Sell
251,548
-22,896
-8% -$245K ﹤0.01% 2286
2020
Q2
$3.14M Sell
274,444
-525,247
-66% -$5.95M ﹤0.01% 2133
2020
Q1
$8.28M Sell
799,691
-220,168
-22% -$2.73M ﹤0.01% 1411
2019
Q4
$16.7M Sell
1,019,859
-144,247
-12% -$2.18M 0.01% 1271
2019
Q3
$15.5M Buy
1,164,106
+213,959
+23% +$2.98M 0.01% 1296
2019
Q2
$13.4M Buy
+950,147
New +$15.1M 0.01% 1419

Other funds holding VNDA